产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
CDK8分子别名
Cyclin-dependent kinase 8; Cell division protein kinase 8; Mediator complex subunit CDK8; Mediator of RNA polymerase II transcription subunit CDK8; Protein kinase K35免疫原
Recombinant Protein细胞定位
NucleusAccession
P49336克隆号
S-1627-70抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Hu, Ms, Rt阳性样本
K562, SW480, HCT 116, HT-29, HeLa, NIH/3T3, RAW264.7, mouse testis, rat testis预测反应种属
(反应种属缩写表)Sq, Mk, C. aethiops, Rb纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
ICFCM
ICC ?
WB
稀释度
应用 稀释度 推荐种属 WB 1:1000 Hu, Ms, Rt ICC 1:500 Hu ICFCM 1:50 Hu
CDK8 (cyclin-dependent kinase 8) is a serine/threonine kinase that plays a crucial role in regulating DNA transcription and cell cycle progression. It forms a module with Cyclin C (CCNC), Med12, and Med13, which associates with the Mediator complex to modulate gene transcription. CDK8 phosphorylates the C-terminal domain of RNA polymerase II, influencing transcriptional elongation. In cancer, CDK8 acts as a positive regulator of oncogene-induced proliferation by recruiting pTEF-B and BRD4 to oncogenic genes, promoting efficient transcriptional elongation. However, it can also inhibit Mediator-dependent super-enhancer driven transcription in acute myeloid leukemia (AML), suggesting its role may vary depending on the oncogenic context. Additionally, CDK8 is often amplified in colorectal cancer, where it modulates beta-catenin activity, contributing to tumor progression.
免疫印迹
WB result of CDK8 Recombinant Rabbit mAb
Primary antibody: CDK8 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: K562 whole cell lysate 20 µg
Lane 2: SW480 whole cell lysate 20 µg
Lane 3: HCT 116 whole cell lysate 20 µg
Lane 4: HT-29 whole cell lysate 20 µg
Lane 5: HeLa whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 53 kDa
Observed MW: 55 kDaWB result of CDK8 Recombinant Rabbit mAb
Primary antibody: CDK8 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: NIH/3T3 whole cell lysate 20 µg
Lane 2: RAW264.7 whole cell lysate 20 µg
Lane 3: mouse testis lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 53 kDa
Observed MW: 55 kDaWB result of CDK8 Recombinant Rabbit mAb
Primary antibody: CDK8 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: rat testis lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 53 kDa
Observed MW: 55 kDa
流式分析
Flow cytometric analysis of HCT116 (Human colorectal carcinoma epithelial cell) labelling CDK8 antibody at 1/50 dilution (1 μg) / (Red) compared with a Rabbit monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Rabbit IgG Alexa Fluor® 488 was used as the secondary antibody.
免疫细胞化学
ICC shows positive staining in HCT116 cells. Anti- CDK8 antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定







评论(0)